ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 650

Clinical Variables Associated with Thrombosis At Systemic Lupus Erythematosus Diagnosis. Differences Between Patients with Positive/Negative Lupus Anticoagulant

Andrea Hinojosa-Azaola1, Alba Cicero-Casarrubias1, Mario César Ocampo-Torres1, Juanita Romero-Díaz1 and Jorge Sánchez-Guerrero2, 1Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, 2Rheumatology, Mount Sinai Hospital and University Health Network, Toronto Canada, Toronto, ON, Canada

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Thrombosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Lupus Erythematosus: Clinical Aspects

Session Type: Abstract Submissions (ACR)

Background/Purpose: Thrombosis in patients with Systemic Lupus Erythematosus (SLE) is a major cause of morbidity, it occurs in 9-37%, at younger age, and it represents 27% of mortality. Lupus anticoagulant (LA) is strongly associated with thrombosis; however, most events occur in patients who are negative for LA. The aim of our study was to determine the baseline characteristics associated with thrombosis in an inception cohort of SLE patients and in the subset of patients without LA.  

Methods: A longitudinal inception cohort of 223 SLE patients (less than 12 months of accrual ≥4 criteria), predominantly female (90%), mean age 27.2 years at diagnosis, was studied. Baseline evaluation included medical history, physical exam, clinical variables, SLE characteristics, SLE activity (SLEDAI-2K), modified damage index (SLICC/DI), autoantibodies, laboratory tests, homocystein and high-sensitivity C-reactive protein (hs-CRP). Thrombotic events were diagnosed on clinical manifestations and confirmed by appropriate studies. Statistical analyses: Descriptive statistics, Student T-test, Mann-Whitney U-test, Chi-square, Fisher exact test, Logistic Regression. P <0.05 

Results: During 1269 patient-years of follow-up, thrombosis occurred in 35 patients (16%), incidence rate 25.6 per 1000 patient-years. Most of the events (57%) occurred at onset or during the first year of diagnosis of SLE. At baseline, patients with thrombosis had lower body mass index (BMI) (p=0.03), smoking (p=0.02), vascular insufficiency (p=0.05), immobilization (p<0.0001), recent surgery (p=0.004), anti-RNP (p=0.04), lupus anticoagulant (LA) (p=0.006), and higher modified SLICC/DI (p=0.03). Since only 8/35 thromboses were associated to LA, we identified those variables associated with thromboses in patients with LA negative: smoking (p=0.004), vascular insufficiency (p=0.03), immobilization (p<0.0001), serositis (p=0.04), and hs-CRP (p=0.02). In the multivariate analysis, BMI (OR 0.79 95% CI 0.65-0.95, p=0.016), anti-RNP (OR 1.02 95%CI 1.00-1.03, p=0.003) and LA+ (OR 8.05 95% CI 1.75-36.88, p=0.007) were independent risk factors for thrombosis in the general cohort. After excluding patients with LA, smoking (OR 6.1, 95% CI 1.7-21.8 p=0.006), vascular insufficiency (OR 28.7 95% CI 2.4-342.9, p=0.008), and immobilization (OR 31.3 95%CI 2.6-381.4, p=0.007) were independent risk factors for thrombosis. 

Conclusion: Patients with SLE are at an increased risk of thrombosis, particularly during the first year of diagnosis. Although LA is a strong risk factor, most thrombotic events occur in patients without LA; in this subset, smoking, immobilization and vascular insufficiency are the most important. All of them are potentially modifiable.


Disclosure:

A. Hinojosa-Azaola,
None;

A. Cicero-Casarrubias,
None;

M. C. Ocampo-Torres,
None;

J. Romero-Díaz,
None;

J. Sánchez-Guerrero,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/clinical-variables-associated-with-thrombosis-at-systemic-lupus-erythematosus-diagnosis-differences-between-patients-with-positivenegative-lupus-anticoagulant/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology